601 related articles for article (PubMed ID: 11601258)
21. Differences in portal hemodynamics in cirrhosis and idiopathic portal hypertension.
Ohnishi K; Chin N; Tanaka H; Iida S; Sato S; Terabayashi H; Nomura F
Am J Gastroenterol; 1989 Apr; 84(4):409-12. PubMed ID: 2929562
[TBL] [Abstract][Full Text] [Related]
22. Captopril reduces portal pressure effectively in portal hypertensive patients with low portal venous velocity.
Baik SK; Park DH; Kim MY; Choi YJ; Kim HS; Lee DK; Kwon SO; Kim YJ; Park JW; Chang SJ
J Gastroenterol; 2003; 38(12):1150-4. PubMed ID: 14714252
[TBL] [Abstract][Full Text] [Related]
23. Effect of transjugular intrahepatic portosystemic shunt formation on portal hypertensive gastropathy and gastric circulation.
Mezawa S; Homma H; Ohta H; Masuko E; Doi T; Miyanishi K; Takada K; Kukitsu T; Sato T; Niitsu Y
Am J Gastroenterol; 2001 Apr; 96(4):1155-9. PubMed ID: 11316163
[TBL] [Abstract][Full Text] [Related]
24. Clinical and laboratory predictors of esophageal varices in children and adolescents with portal hypertension syndrome.
Fagundes ED; Ferreira AR; Roquete ML; Penna FJ; Goulart EM; Figueiredo Filho PP; Bittencourt PF; Carvalho SD; Albuquerque W
J Pediatr Gastroenterol Nutr; 2008 Feb; 46(2):178-83. PubMed ID: 18223377
[TBL] [Abstract][Full Text] [Related]
25. [A clinical study on splanchnic hemodynamic changes after orthotopic liver transplantation for patients with portal hypertension].
Jiang SM; Zhou GW; Shen C; Yan JQ; Wan L; Li QY; Yang WP; Shen BY; Chen H; Peng CH; Li HW
Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(22):1699-702. PubMed ID: 19094727
[TBL] [Abstract][Full Text] [Related]
26. Portal hemodynamics as predictors of high risk esophageal varices in cirrhotic patients.
Tarzamni MK; Somi MH; Farhang S; Jalilvand M
World J Gastroenterol; 2008 Mar; 14(12):1898-902. PubMed ID: 18350629
[TBL] [Abstract][Full Text] [Related]
27. Portal venous blood flow unaltered in cirrhotic patients given metoclopramide injections.
Ohta M; Tomikawa M; Hashizume M; Ueno K; Tanoue K; Sugimachi K
Ital J Gastroenterol; 1995 Jun; 27(5):239-43. PubMed ID: 8541573
[TBL] [Abstract][Full Text] [Related]
28. The effect of splenomegaly on splanchnic hemodynamics in nonalcoholic cirrhosis after distal splenorenal shunt and splenopancreatic disconnection.
Takagi K; Ashida H; Utsunomiya J
Hepatology; 1994 Aug; 20(2):342-8. PubMed ID: 8045494
[TBL] [Abstract][Full Text] [Related]
29. Non-invasive model predicting clinically-significant portal hypertension in patients with advanced fibrosis.
Park SH; Park TE; Kim YM; Kim SJ; Baik GH; Kim JB; Kim DJ
J Gastroenterol Hepatol; 2009 Jul; 24(7):1289-93. PubMed ID: 19682196
[TBL] [Abstract][Full Text] [Related]
30. Effects of combined splenorenal shunt devascularization and devascularization only on hemodynamics of the portal venous system in patients with portal hypertension.
Cao H; Hua R; Wu ZY
Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):385-8. PubMed ID: 16109521
[TBL] [Abstract][Full Text] [Related]
31. Hepatic venous pressure gradient does not correlate with the presence and the severity of portal hypertensive gastropathy in patients with liver cirrhosis.
Bellis L; Nicodemo S; Galossi A; Guarisco R; Spilabotti L; Durola L; Dell'Unto O; Puoti C
J Gastrointestin Liver Dis; 2007 Sep; 16(3):273-7. PubMed ID: 17925921
[TBL] [Abstract][Full Text] [Related]
32. Wall shear stress in portal vein of cirrhotic patients with portal hypertension.
Wei W; Pu YS; Wang XK; Jiang A; Zhou R; Li Y; Zhang QJ; Wei YJ; Chen B; Li ZF
World J Gastroenterol; 2017 May; 23(18):3279-3286. PubMed ID: 28566887
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of portal hypertension by endoscopic esophageal ligation of varicose veins combined with partial splenic embolization].
Liu B; Xu RY; Qiu WS; Lin N; Chen TF; Huang FZ; Liu XY
Zhonghua Wai Ke Za Zhi; 2003 Oct; 41(10):721-3. PubMed ID: 14766039
[TBL] [Abstract][Full Text] [Related]
34. Clinical usefulness of the angiotensin II receptor antagonist losartan in patients with portal hypertensive gastropathy.
Wagatsuma Y; Naritaka Y; Shimakawa T; Kanako H; Keiichiro I; Shunichi S; Konno S; Katsube T; Ogawa K
Hepatogastroenterology; 2006; 53(68):171-4. PubMed ID: 16608017
[TBL] [Abstract][Full Text] [Related]
35. The influence of endoscopic variceal ligation on the portal pressure gradient in cirrhotics.
Pereira-Lima JC; Zanette M; Lopes CV; de Mattos AA
Hepatogastroenterology; 2003; 50(49):102-6. PubMed ID: 12630002
[TBL] [Abstract][Full Text] [Related]
36. Portal pressure response to losartan compared with propranolol in patients with cirrhosis.
De BK; Bandyopadhyay K; Das TK; Das D; Biswas PK; Majumdar D; Mandal SK; Ray S; Dasgupta S
Am J Gastroenterol; 2003 Jun; 98(6):1371-6. PubMed ID: 12818283
[TBL] [Abstract][Full Text] [Related]
37. Increased blood flow through the portal system in cirrhotic rats.
Vorobioff J; Bredfeldt JE; Groszmann RJ
Gastroenterology; 1984 Nov; 87(5):1120-6. PubMed ID: 6479534
[TBL] [Abstract][Full Text] [Related]
38. [Gallbladder contractile function in patients with portal hypertension].
Zhu JF
Zhonghua Wai Ke Za Zhi; 1993 Jan; 31(1):34-6. PubMed ID: 8404340
[TBL] [Abstract][Full Text] [Related]
39. The postprandial portal flow is related to the severity of portal hypertension and liver cirrhosis.
Ludwig D; Schwarting K; Korbel CM; Brüning A; Schiefer B; Stange EF
J Hepatol; 1998 Apr; 28(4):631-8. PubMed ID: 9566832
[TBL] [Abstract][Full Text] [Related]
40. The effects of endoscopic sclerotherapy combined with transhepatic variceal obliteration on portal hemodynamics.
Ohnishi K; Nakata H; Terabayashi H; Tanaka H; Tsunoda T; Iida S; Nomura F
Am J Gastroenterol; 1987 Nov; 82(11):1138-42. PubMed ID: 3673992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
